Related Experiment Video
Updated: Sep 14, 2025

An Optogenetic Method to Control and Analyze Gene Expression Patterns in Cell-to-cell Interactions
Published on: March 22, 2018
Acousto-optogenetics bandpass stabilizer: A programmable platform for mapping single-cell phenotypic life
Yuxin Wang1, Yue Quan1, Shizheng Zhou1
1Joint Key Laboratory of the Ministry of Education, Institute of Applied Physics and Materials Engineering, University of Macau, Avenida da Universidade, Taipa, 999078, Macau.
Abstract:
Photobleaching-induced signal decay undermines the accuracy of fluorescence-based drug screening across multiple disease models (e.g., HER2/EGFR-targeted therapies). Traditional phototoxicity mitigation strategies, primarily through reduced illumination, inevitably compromise imaging resolution and further providing false positive/false negative. Here, we introduce an innovative active photobleaching intervention strategy to solve these problems with the potential for broad applicability across a wide range of cell species. We employ the ultra-low-frequency (500-2000 Hz) acoustic modulation to control 3D cellular rotation (precisely in x-y/y-z planes) with a linearly tunable rotational speed, establishing the first quantitative framework linking acoustic parameters to photobleaching kinetics. Our results indicate that acoustic frequency scanning exerts a bandpass-filter effect on photobleaching half-life, peaking at 1500 Hz and achieving approximately 30-fold fluorescence preservation compared to static conditions. By harnessing our newly developed Acousto-Optogenetics Bandpass Stabilizer, we transform phototoxicity into a tunable parameter, thereby enabling artifact-free drug response analysis. While maintaining maximal photostability, frequency-division multiplexing further permits real-time calcium flux monitoring during optogenetic activation. Complementing this, we engineer FlowMind, an AI-powered software, to automate single-cell dynamic library processing. As proof of concept, screening calcium channel blockers under optimal photostability conditions reveals significant variations in drug screening sensitivity. By integrating acoustic modulation with optogenetics, this paradigm not only pioneers the programmable control of photostability via acoustics, but also catalyzes a transformative shift in precision oncology, heralding a new era of patient-tailored therapeutic regimens with enhanced clinical predictability.
Insights
This study introduces acoustic modulation to control cell rotation, significantly reducing photobleaching in fluorescence imaging. This innovation enables artifact-free drug screening and enhances precision oncology by improving clinical predictability.
Area of Science:
- Biophysics
- Cell Biology
- Pharmacology
Background:
- Photobleaching limits fluorescence-based drug screening accuracy, leading to false positives/negatives.
- Current phototoxicity mitigation strategies compromise imaging resolution.
Purpose of the Study:
- To develop an active photobleaching intervention strategy using acoustic modulation.
- To establish a quantitative framework linking acoustic parameters to photobleaching kinetics.
- To enable artifact-free drug response analysis and enhance precision oncology.
Main Methods:
- Employing ultra-low-frequency acoustic modulation (500-2000 Hz) for 3D cellular rotation.
- Utilizing an Acousto-Optogenetics Bandpass Stabilizer for tunable phototoxicity control.
- Developing FlowMind, an AI-powered software for automated single-cell dynamic library processing.
Main Results:
- Acoustic frequency scanning demonstrated a bandpass-filter effect on photobleaching, peaking at 1500 Hz.
- Achieved approximately 30-fold fluorescence preservation compared to static conditions.
- Demonstrated significant variations in drug screening sensitivity for calcium channel blockers.
Conclusions:
- Acoustic modulation offers programmable control of photostability, revolutionizing fluorescence-based assays.
- The developed Acousto-Optogenetics Bandpass Stabilizer and FlowMind software enable artifact-free drug screening.
- This paradigm shift promises enhanced clinical predictability in patient-tailored therapeutic regimens for precision oncology.
More Related Videos
10:01High-Throughput Optical Controlling and Recording Calcium Signal in iPSC-Derived Cardiomyocytes for Toxicity Testing and Phenotypic Drug Screening
Published on: March 31, 2022
08:49Mapping the Cellular Distribution of an Optogenetic Protein Using a Light-Stimulation Grid
Published on: January 26, 2024